DK121120B - Fremgangsmåde til fremstilling af 3-hydroxy-Δ<1,5>-androstadiener eller 3-estere eller 3-ethere deraf. - Google Patents

Fremgangsmåde til fremstilling af 3-hydroxy-Δ<1,5>-androstadiener eller 3-estere eller 3-ethere deraf.

Info

Publication number
DK121120B
DK121120B DK20564AA DK20564A DK121120B DK 121120 B DK121120 B DK 121120B DK 20564A A DK20564A A DK 20564AA DK 20564 A DK20564 A DK 20564A DK 121120 B DK121120 B DK 121120B
Authority
DK
Denmark
Prior art keywords
androstadienes
ethers
hydroxy
esters
preparation
Prior art date
Application number
DK20564AA
Other languages
English (en)
Inventor
E Oliveto
M Tanabe
Original Assignee
Scherico Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US251747A external-priority patent/US3127430A/en
Priority claimed from US251744A external-priority patent/US3127428A/en
Application filed by Scherico Ltd filed Critical Scherico Ltd
Publication of DK121120B publication Critical patent/DK121120B/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A61K31/569—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone substituted in position 17 alpha, e.g. ethisterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A63—SPORTS; GAMES; AMUSEMENTS
    • A63F—CARD, BOARD, OR ROULETTE GAMES; INDOOR GAMES USING SMALL MOVING PLAYING BODIES; VIDEO GAMES; GAMES NOT OTHERWISE PROVIDED FOR
    • A63F1/00—Card games
    • A63F1/06—Card games appurtenances
    • A63F1/18—Score computers; Miscellaneous indicators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J75/00—Processes for the preparation of steroids in general

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Multimedia (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK20564AA 1963-01-16 1964-01-15 Fremgangsmåde til fremstilling af 3-hydroxy-Δ<1,5>-androstadiener eller 3-estere eller 3-ethere deraf. DK121120B (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US251747A US3127430A (en) 1963-01-16 1963-01-16 17alpha-methyl-1, 5-androstadienes-17beta-ol-3-one and derivatives thereof
US251744A US3127428A (en) 1963-01-16 1963-01-16 Process for converting a 3-keto-delta-steroid to the corresponding 3-keto delta-compound
US263441A US3332967A (en) 1963-01-16 1963-03-07 3-hydroxy-1, 5-bis-dehydro steroids and methods for their manufacture

Publications (1)

Publication Number Publication Date
DK121120B true DK121120B (da) 1971-09-13

Family

ID=27400477

Family Applications (1)

Application Number Title Priority Date Filing Date
DK20564AA DK121120B (da) 1963-01-16 1964-01-15 Fremgangsmåde til fremstilling af 3-hydroxy-Δ<1,5>-androstadiener eller 3-estere eller 3-ethere deraf.

Country Status (9)

Country Link
US (1) US3332967A (da)
BE (1) BE642575A (da)
BR (1) BR6456127D0 (da)
CH (1) CH471829A (da)
DE (2) DE1793618C3 (da)
DK (1) DK121120B (da)
ES (1) ES295331A1 (da)
FR (2) FR1602256A (da)
SE (1) SE321468B (da)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3928398A (en) * 1973-11-01 1975-12-23 Richardson Merrell Inc Derivatives of 7{60 -methylestr-4-en-3{60 ,17{62 -diol
US4340538A (en) * 1980-07-21 1982-07-20 The Upjohn Company Process for producing 6α-fluoro-Δ1,4 -3-keto steroids
US4383947A (en) * 1981-07-24 1983-05-17 The Upjohn Company Introduction of a fluorine atom
US5879711A (en) * 1997-11-07 1999-03-09 Sequeira; Joel A. Stable antiandrogenic gel composition
CA2522784C (en) * 2003-04-01 2012-06-19 Hollis-Eden Pharmaceuticals, Inc. Antiandrogens with marginal agonist activity and methods of use

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3127430A (en) * 1963-01-16 1964-03-31 Schering Corp 17alpha-methyl-1, 5-androstadienes-17beta-ol-3-one and derivatives thereof
US3127428A (en) * 1963-01-16 1964-03-31 Schering Corp Process for converting a 3-keto-delta-steroid to the corresponding 3-keto delta-compound

Also Published As

Publication number Publication date
FR1602256A (en) 1970-11-02
FR4300M (da) 1966-07-25
ES295331A1 (es) 1964-06-01
BE642575A (da)
CH471829A (de) 1969-04-30
BR6456127D0 (pt) 1973-07-17
DE1493145B1 (de) 1971-11-25
US3332967A (en) 1967-07-25
DE1793618B2 (da) 1975-03-06
SE321468B (da) 1970-03-09
DE1793618C3 (de) 1975-10-23
DE1793618A1 (de) 1972-02-03

Similar Documents

Publication Publication Date Title
DK116205B (da) Analogifremgangsmåde til fremstilling af 17α-alkanoyloxy-9α-halogen-16β-methyl-11β,21-dihydroxy-Δ&lt;1,4&gt;-pregnadien-3,20-dioner.
DK106552C (da) Fremgangsmåde til fremstilling af substituerede 6,7-benzomorphaner.
DK117957B (da) Fremgangsmåde til fremstilling af 13β-alkyl-3-oxogona-4,9,11-triener.
DK108364C (da) Fremgangsmåde til fremstilling af substituerede phenylamino-1,3-diazacyclopentener-(2)-, eller syreadditionssalte heraf.
DK106185C (da) Fremgangsmåde til fremstilling af 17α-acyloxy-4,6-pregnadien-20-oner.
DK121120B (da) Fremgangsmåde til fremstilling af 3-hydroxy-Δ&lt;1,5&gt;-androstadiener eller 3-estere eller 3-ethere deraf.
DK119107B (da) Fremgangsmåde til fremstilling af 11β-hydroperoxy-3-oxo-13-alkyl-Δ&lt;4,9&gt;-gonadiener.
DK115547B (da) Fremgangsmåde til fremstilling af 17α-acyloxy-16-methyl-9α-flour-Δ&lt;1,4&gt;-pregnadien-3,20-dioner.
DK118557B (da) Fremgangsmåde til fremstilling af 17α-acyloxy-11β-hydroxy-Δ&lt;4&gt;-pregnen-3,20-dioner.
DK119010B (da) Fremgangsmåde til fremstilling af 1,3-dihydro-5-aryl-2H-1,4-benzodiazepin-2-on-4-oxider eller tilsvarende deoxyforbindelser.
DK108004C (da) Fremgangsmåde til fremstilling af 2,6-dichlorbenzonitril.
DK115537B (da) Fremgangsmåde til fremstilling af 6-methyl-Δ&lt;8,9&gt;-ergolen-8-carboxylsyre eller lysergsyre.
DK106329C (da) Fremgangsmåde til fremstilling af 3,20-dioxo-19-nor-4,9,11-pregnatrien.
DK113585B (da) Analogifremgangsmåde til fremstilling af 15, 16β-methylen-3-keto-Δ&lt;4&gt;-19-nor-androsten-17β-oler eller estere deraf.
DK106494C (da) Fremgangsmåde til fremstilling af 11β-hydroxy-17α-ethinylestradiol eller dets 3-estere eller 3-ethere.
DK109260C (da) Fremgangsmåde til fremstilling af 3,5-diklor-2, 6-dimetyl-4-pyridinol.
DK109895C (da) Fremgangsmåde til fremstilling af 1,3-dioxo-2-alkyl-cyclopentaner.
DK114904B (da) Fremgangsmåde til fremstilling af 3,5-diiodthyroniner.
DK108919C (da) Fremgangsmåde til fremstilling af 1,2-diaryl-4-alkyl-3,5-dioxo-pyrazolidiner eller salte deraf.
DK108211C (da) Fremgangsmåde til fremstilling af Δ&lt;4,9&gt;-estradien-3β,17-dioler eller 3-monoestere, 17-monoestere eller 3,17-diestere heraf.
DK118400B (da) Fremgangsmåde til fremstilling af Δ&lt;14&gt;-3,20-diketo-21-acyloxy-5β-pregnener eller Δ&lt;4,14&gt;-3,20-diketo-21-acyloxy-pregnadiener.
DK112381B (da) Fremgangsmåde til fremstilling af 16-fluormethylen-17α-hydroxy-20-keto-steroider af pregnan-, 19-nor-pregnan- eller iso-pregnanrækken eller 17α-estere deraf.
DK112449B (da) Fremgangsmåde til fremstilling af 2,3-dihydro-5-pyridyl-1H-1,4-benzodiazepiner eller syreadditionssalte deraf.
DK103832C (da) Fremgangsmåde til fremstilling af 4-(N&lt;1&gt;-alkanoylsulfanilamido)-5,6-dimethoxy-pyrimidiner.
DK104170C (da) Fremgangsmåde til fremstilling af 3-alkoxy- eller 3-aralkoxy-16-amino-Δ&lt;3,5&gt;-pregnadien-17α-ol-20-oner, eller 16-amino-Δ&lt;4&gt;-pregnen-17α-ol-3,20-dioner.